COGNATE BIOSERVICES
Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.
COGNATE BIOSERVICES
Social Links:
Industry:
Biotechnology Health Care Manufacturing
Founded:
2002-01-01
Address:
Hanover, Maryland, United States
Country:
United States
Website Url:
http://www.cognatebioservices.com
Total Employee:
101+
Status:
Active
Contact:
901-541-9800
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google Cloudflare DNS Accelerated Mobile Pages Mimecast KnowBe4
Similar Organizations
Biotix
Biotix is a manufacturer of laboratory consumable tools and liquid handling solutions.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-04 | Cobra Biologics | Cobra Biologics acquired by Cognate BioServices | N/A |
Investors List
Medivate Partners
Medivate Partners investment in Series B - Cognate BioServices
EW Healthcare Partners
EW Healthcare Partners investment in Series B - Cognate BioServices
EW Healthcare Partners
EW Healthcare Partners investment in Venture Round - Cognate BioServices
Tennenbaum Capital Partners
Tennenbaum Capital Partners investment in Venture Round - Cognate BioServices
Medivate Partners
Medivate Partners investment in Venture Round - Cognate BioServices
Official Site Inspections
http://www.cognatebioservices.com
- Host name: 52.177.206.73
- IP address: 52.177.206.73
- Location: Boydton United States
- Latitude: 36.6534
- Longitude: -78.375
- Metro Code: 560
- Timezone: America/New_York
- Postal: 23917
More informations about "Cognate BioServices"
Cognate BioServices, a Charles River Company | LinkedIn
Cognate BioServices is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. We pride ourselves in the level of quality and experience ...See details»
Cognate BioServices Is Now Part of Charles River
In April 2021, Charles River acquired Cognate BioServices, the premier contract development and manufacturing organization for cell and gene-mediated cell therapy. Cognate, along with gene therapy CDMO providers Cobra Biologics …See details»
Investor Relations - Charles River Laboratories International, Inc.
Feb 17, 2021 WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 17, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive …See details»
Cognate BioServices - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number 901-541-9800; Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific …See details»
Charles River Completes the Acquisition of Cognate BioServices
Mar 29, 2021 Our acquisition of Cognate BioServices and its Cobra Biologics facilities create a unique end-to-end solution for your development and delivery of novel cell and gene therapies.See details»
Cognate BioServices - Charles River Laboratories
Cognate BioServices, Inc., a Charles River Company, is the premier commercial-ready CDMO for cell and gene therapy needs. We are a dynamic, results-driven organization focused on …See details»
Cognate BioServices, a Charles River Company - leadiq.com
Jan 31, 2022 For instance, in February 2021, Charles River Laboratories, Inc. has announced the acquisition of Cognate BioServices, Inc., a leading cell and gene therapy contract …See details»
Charles River Laboratories Completes the Acquisition of Cognate ...
Mar 29, 2021 WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously …See details»
Cognate BioServices Announces Major Expansion of …
MEMPHIS, Tenn., Jan. 14, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its …See details»
Cognate BioServices closes Series B and completes acquisition of …
Jan 21 2020. MEMPHIS, Tennessee—Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy …See details»
Cognate BioServices Reveals New Brand Identity with ... - BioSpace
MEMPHIS, Tenn., Aug. 6, 2020 /PRNewswire/ -- Cognate BioServices, Inc., the premier contract development and manufacturing organization (CDMO) specializing in cell and cell-mediated …See details»
Cognate Therapeutics, Inc. Changes Name To Cognate ... - BioSpace
BALTIMORE, June 19 /PRNewswire/ -- Cognate Therapeutics, Inc. today announced it has changed its name to Cognate BioServices, Inc. As a leader in the provision of biotechnology …See details»
Cognate BioServices announces acquisition of Cobra Biologics
Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products and Cobra Biologics, a leading …See details»
Cognate BioServices announces acquisition of Cobra Biologics
Nov 4, 2019 Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular …See details»
Cognate BioServices closes Series B and completes ... - Newswire
Jan 21, 2020 Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular …See details»
Cognate BioServices closes Series B and completes acquisition of …
Jan 21, 2020 Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular …See details»
EW Healthcare Partners - Portfolio - Cognate Bioservices
Mar 29, 2021 Cognate BioServices, Inc. was a privately-held contract development and manufacturing organization (CDMO) developing cell-based products and therapies Cognate …See details»
Cognate BioServices announces acquisition of Cobra Biologics
MEMPHIS, Tenn., Nov. 4, 2019 /PRNewswire/ -- Cognate BioServices, Inc. (Cognate), a leading contract development and manufacturing organization (CDMO) specialized in cell and cell …See details»
Cognate BioServices announces acquisition of Cobra Biologics
Nov 4, 2019 Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular …See details»
Cognate BioServices and Nucleus Biologics announce partnership …
Jan 27, 2021 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready global CDMO in the Cell and Gene Therapy industry, and Nucleus Biologics, LLC, The Cell...See details»